J.W. Cole Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Buy |
9,026
+5,198
| +136% | +$2.11M | 0.08% | 249 |
|
|
2025
Q1 | $1.9M | Buy |
3,828
+2,035
| +113% | +$1.01M | 0.06% | 333 |
|
|
2024
Q4 | $933K | Buy |
1,793
+290
| +19% | +$151K | 0.04% | 430 |
|
|
2024
Q3 | $930K | Sell |
1,503
-226
| -13% | -$140K | 0.04% | 412 |
|
|
2024
Q2 | $956K | Sell |
1,729
-2,224
| -56% | -$1.23M | 0.05% | 364 |
|
|
2024
Q1 | $2.3M | Buy |
3,953
+1,711
| +76% | +$994K | 0.12% | 189 |
|
|
2023
Q4 | $1.19M | Buy |
2,242
+559
| +33% | +$297K | 0.07% | 278 |
|
|
2023
Q3 | $852K | Sell |
1,683
-220
| -12% | -$111K | 0.06% | 287 |
|
|
2023
Q2 | $993K | Sell |
1,903
-1,688
| -47% | -$881K | 0.07% | 270 |
|
|
2023
Q1 | $2.07M | Buy |
3,591
+210
| +6% | +$121K | 0.15% | 161 |
|
|
2022
Q4 | $1.86M | Buy |
3,381
+92
| +3% | +$50.7K | 0.14% | 169 |
|
|
2022
Q3 | $1.67M | Buy |
3,289
+54
| +2% | +$27.4K | 0.14% | 177 |
|
|
2022
Q2 | $1.76M | Sell |
3,235
-118
| -4% | -$64.1K | 0.14% | 173 |
|
|
2022
Q1 | $1.98M | Buy |
3,353
+227
| +7% | +$134K | 0.13% | 177 |
|
|
2021
Q4 | $2.09M | Buy |
3,126
+723
| +30% | +$482K | 0.14% | 179 |
|
|
2021
Q3 | $1.37M | Sell |
2,403
-112
| -4% | -$64K | 0.1% | 136 |
|
|
2021
Q2 | $1.27M | Sell |
2,515
-1,794
| -42% | -$905K | 0.1% | 231 |
|
|
2021
Q1 | $1.97M | Buy |
4,309
+283
| +7% | +$129K | 0.19% | 129 |
|
|
2020
Q4 | $1.88M | Buy |
4,026
+495
| +14% | +$231K | 0.19% | 122 |
|
|
2020
Q3 | $1.56M | Buy |
+3,531
| New | +$1.56M | 0.12% | 185 |
|
|
2020
Q2 | – | Sell |
-1,984
| Closed | -$563K | – | 318 |
|
|
2020
Q1 | $563K | Sell |
1,984
-1,164
| -37% | -$330K | 1.09% | 26 |
|
|
2019
Q4 | $1.02M | Buy |
+3,148
| New | +$1.02M | 0.13% | 182 |
|